Not all women diagnosed with PCOS share the same cardiovascular risk profiles

Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes

Long-term consequences of polycystic ovary syndrome on cardiovascular risk

The importance of insulin resistance in polycystic ovary syndrome

A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome

The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome

Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective

Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance

Periodontal disease in polycystic ovary syndrome

Polycystic ovary syndrome: an ancient disorder?

Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome

Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro

Lower serum apelin levels in women with polycystic ovary syndrome

Ontogeny of the ovary in polycystic ovary syndrome

Abnormal aminotransferase activity in women with polycystic ovary syndrome